Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
about
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseCholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseAre we prepared to deal with the Alzheimer's disease pandemic?High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.Targeting Abeta and tau in Alzheimer's disease, an early interim reportDeficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal DeathEndolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet.Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptidesAdvances on the understanding of the origins of synaptic pathology in AD.Generation of a new transgenic mouse model for assessment of tau gene silencing therapies.Current concepts in Alzheimer's disease: a multidisciplinary review.Towards retinoid therapy for Alzheimer's disease.Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease.Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease.Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Biochemistry and cell biology of tau protein in neurofibrillary degenerationStabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?Calcium signaling and neurodegenerative diseases.An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide.Calcium signaling and neurodegeneration.A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1.Amyloid beta toxicity dependent upon endothelial cell state.
P2860
Q24627125-BBD9942B-D6D1-48D2-A635-D91CED0DDD2BQ28287090-20A6659A-18AF-4C90-AC99-612184A9BF7AQ30392542-322E1C60-34D8-4FF2-866B-CB04617BAE6AQ33523403-356216F2-78D5-41CF-8DD4-0C1E319CAADDQ33829008-E299CCBD-7F78-4F52-9301-3FF48158ADA4Q34233456-5B8287A5-DB46-4A60-999B-A1B5CF493F4EQ34985303-093C9560-077A-4682-B054-C44C14E22B58Q36201070-6C3B49FD-C255-4A4D-A1EF-C28C0F17DB47Q36279869-E5787100-6235-42D7-8B78-44510BBFA98FQ37108156-B27C95E7-20F0-4038-AAB3-9CE3BB57DBA4Q37232081-B7EBDE3F-0C38-4CBD-9E09-4A3B1FCBE49CQ37360292-815C85D9-CC4B-43E2-A97C-ADD1136CB19CQ37515508-8C9AFF92-759B-44D8-A207-17DDB32867CBQ37736181-4D44B908-3844-41C6-BC92-F79517ED5343Q37773826-BB8551F9-121F-4459-91B3-9A8F7EB6C748Q37961834-C58D3FEE-DE58-487B-A115-E9B9B1B578CAQ37961852-A3B80014-73ED-4557-B5AC-9F523A7ECD6CQ38023859-8BA37F79-BF75-47DA-9CBA-C898CE6FB3FAQ38061635-B8E5F452-D865-438E-9666-20794AEAD6DFQ38583222-F6E08EAA-DAAB-43DC-9BE4-B8B2AE2A0DE3Q38592069-5D568118-F0B0-48BA-8153-F5B11360320EQ39463322-4DF56428-1DB7-486C-833F-EE91675B84F5Q41866952-B4EF3538-261E-404C-83AF-73CB4DA591D7Q42066419-6D5F86B5-8E91-450D-B66F-BBBE82EB9CB4Q42183071-59BAB40B-4A94-401B-BA14-C6DEE0C4C48EQ42532120-548A35B6-E649-433A-87C1-402E86127F67
P2860
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
@en
type
label
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
@en
prefLabel
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
@en
P2093
P356
P1476
Beyond amyloid: the next generation of Alzheimer's disease therapeutics
@en
P2093
Guy R Seabrook
Mark Shearman
Michael Hutton
P304
P356
10.1124/MI.7.5.8
P577
2007-10-01T00:00:00Z